HIV and SARS-CoV-2: the interplay of two wicked problems

European Meeting on HIV & Hepatitis 2022

Eu HIV & Hep Abstracts 2022_56

European Meeting on HIV & Hepatitis 2022

Prevalence and viral load suppression rate among children and adolescents with dual infections (any two of HIV, HBV, and HCV) in Nnewi, Nigeria

European Meeting on HIV & Hepatitis 2022

Proviral DNA for detection of HIV-1 subtype A drug resistance mutations

European Meeting on HIV & Hepatitis 2022

Combined COVID-19 vaccination and hepatitis C virus screening intervention for high-risk populations at a centre for addiction services in Barcelona, Spain

European Meeting on HIV & Hepatitis 2022

Combined COVID-19 vaccination and hepatitis C virus and HIV screening intervention for high- risk populations at a mobile testing unit in Madrid, Spain

European Meeting on HIV & Hepatitis 2022

Community perspectives on self- testing for HIV and HCV in the WHO European region

European Meeting on HIV & Hepatitis 2022

Viral load suppression after three-year Ibalizumab treatment in a multidrug-resistant HIV-1- infected woman: Clinical experience.

European Meeting on HIV & Hepatitis 2022

CASE - HIV+ End-Stage Renal Disease Patient with Immunosuppressive Drug-Drug Interactions Received Successful Transplantation after Ibalizumab Suppressed Switch

European Meeting on HIV & Hepatitis 2022

Clinical course of AIDS with COVID-19 coinfection with prolonged SARS CoV-2 replication despite remdesivir/molnupiravir treatment.

European Meeting on HIV & Hepatitis 2022

A Case of IRIS Syphilis Due to Prozone Effect

European Meeting on HIV & Hepatitis 2022

Addressing Stigma in Health Facilities: Why It Matters and How It Can be Done - Laura Nyblade, PhD

INTEREST 2022 (FR)

Mini - Oral Abstract Presentations VI

INTEREST 2022 (FR)

Mini-Oral Abstract Presentations V

INTEREST 2022 (FR)

Integrating HPV Prevention in Adolescent...University - Sabrina Bakeera-Kitaka, MBChB, MMed, PhD

INTEREST 2022 (FR)

State of the Art Interventions in Improving Pediatric HIV Outcomes in OVC Programs - Grace Mayanja

INTEREST 2022 (FR)

Achieving HIV Epidemic Control Among KPs in Africa - Christopher Akolo, MD, MSc, FWACP

INTEREST 2022 (FR)

Mini-Oral Abstract Presentations IV

INTEREST 2022 (FR)

Mini-Oral Abstract Presentations III

INTEREST 2022 (FR)

Mini-Oral Abstract Presentations II

INTEREST 2022 (FR)

HIV, Non-Communicable Disease, and Aging - Barbara Castelnuovo, MD, PhD

INTEREST 2022 (FR)

Progress in Treatment for Viral Hepatitis...Implications for Treatment - Jürgen Rockstroh, MD

INTEREST 2022 (FR)

Differentiated Care Services including Mental Health for Adolescents - Nicola Willis, MPhil

INTEREST 2022 (FR)

Dolutegravir Treatment Outcomes in Children Including Neonates - Victor Musiime, MD, MMed, PhD

INTEREST 2022 (FR)